Koyfin Home > Directory > Health Care > Iovance Biotherapeutics Inc > Repurchase of Common Stock

Iovance Biotherapeutics Inc Repurchase of Common Stock Chart (IOVA)

Iovance Biotherapeutics Inc annual/quarterly Repurchase of Common Stock from 2015 to 2020.
  • Iovance Biotherapeutics Inc Repurchase of Common Stock for the quarter ending June 06, 2020 was $0m a 40.61% decrease of 0m year over year
  • Iovance Biotherapeutics Inc Repurchase of Common Stock for the last 12 months ending June 06, 2020 was $-1m a 53.00% decrease of 0m year over year
  • Iovance Biotherapeutics Inc Annual Repurchase of Common Stock for 2019 was $0m a 28.53% decrease of 0m from 2018
  • Iovance Biotherapeutics Inc Annual Repurchase of Common Stock for 2018 was $0m a -461.43% increase of 1m from 2017
  • Iovance Biotherapeutics Inc Annual Repurchase of Common Stock for 2017 was $-1m a 48.72% decrease of -1m from 2016
Other Cash Flow Metrics:
  • Iovance Biotherapeutics Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $-28m a 24.94% decrease of -7m year over year
  • Iovance Biotherapeutics Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-16m a 52.18% decrease of -9m year over year
View Chart On Koyfin

Quarterly IOVA Repurchase of Common Stock Data

06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$0m

Annual IOVA Repurchase of Common Stock Data

2019$0m
2018$0m
2017$-1m
2016$-1m